Skip to main content
Erschienen in: Annals of Hematology 2/2004

01.02.2004 | Case Report

Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder

verfasst von: T. Yamamoto, A. Shirakawa, M. Kawaguchi, A. Masuda, T. Nishikawa, M. Kobayashi

Erschienen in: Annals of Hematology | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

This report describes lytic infection with Epstein-Barr virus (EBV) in three cases of hemophagocytic syndrome (HPS) presumably associated with EBV-induced lymphoproliferative disorder. All cases were previously healthy females with ages ranging from 52 to 87 years who showed a fulminant clinical course with accompanying fever, liver dysfunction, and disseminated intravascular coagulation. Cases 1 and 2 showed proliferation of atypical T lymphocytes, and case 3 showed proliferation of atypical B lymphocytes. Hemophagocytic histiocytes were observed in the bone marrow, lymph nodes, spleen, and liver. Atypical lymphocytes in all cases showed a positive reaction for both EBV-encoded small RNA (EBER) indicating latent infection with EBV and immediate early mRNAs of the Bam HI fragment of lower stranded frame (BHLF), indicating lytic infection by in situ hybridization. Interestingly, BHLF-positive cells were predominant in all cases. It is possible that reactivation of EBV infection may be involved in triggering the induction of cytokines and abnormal activation of histiocytes.
Literatur
1.
Zurück zum Zitat Arcenas R, Widen RH (2002) Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol 23:20.CrossRef Arcenas R, Widen RH (2002) Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol 23:20.CrossRef
2.
Zurück zum Zitat Cui S, Maruoka Y, Ando T, Kobayashi M, Ogiuchi H (2001) Role of Epstein-Barr virus infection in oral diseases. J Tokyo Wom Med Univ 71:7-15 Cui S, Maruoka Y, Ando T, Kobayashi M, Ogiuchi H (2001) Role of Epstein-Barr virus infection in oral diseases. J Tokyo Wom Med Univ 71:7-15
3.
Zurück zum Zitat Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703 Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703
4.
Zurück zum Zitat Gaillard F, Mechinaud-Lacroix F, Papin S, Moreau A, Mollat C, Fiche M, Peitler S, de Faucal PJ, Rousselet M-C, Praloran V, Harousseau J-L (1992) Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol 98:324–333PubMed Gaillard F, Mechinaud-Lacroix F, Papin S, Moreau A, Mollat C, Fiche M, Peitler S, de Faucal PJ, Rousselet M-C, Praloran V, Harousseau J-L (1992) Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol 98:324–333PubMed
5.
Zurück zum Zitat Hopwood PA, Brooks L, Parratt R, Hunt BJ, Maria B, Alero TJ, Magdi Y, Crawford DH (2002) Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 74:194–202PubMed Hopwood PA, Brooks L, Parratt R, Hunt BJ, Maria B, Alero TJ, Magdi Y, Crawford DH (2002) Persistent Epstein-Barr virus infection: unrestricted latent and lytic viral gene expression in healthy immunosuppressed transplant recipients. Transplantation 74:194–202PubMed
6.
Zurück zum Zitat Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL (2002) Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Anticancer Res 22:4065–4071PubMed Hsu CH, Hergenhahn M, Chuang SE, Yeh PY, Wu TC, Gao M, Cheng AL (2002) Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin. Anticancer Res 22:4065–4071PubMed
7.
Zurück zum Zitat Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135–151PubMed Imashuku S (1997) Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:135–151PubMed
8.
Zurück zum Zitat Jaffe ES, Chan JKC, Su I-J, Frizzera G, Mori S, Feller AC, Ho FCS (1996) Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Am J Surg Pathol 20:103–111PubMed Jaffe ES, Chan JKC, Su I-J, Frizzera G, Mori S, Feller AC, Ho FCS (1996) Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Am J Surg Pathol 20:103–111PubMed
9.
Zurück zum Zitat Kim IS, Park CK, Kim H, Lee YY, Ahn MJ, Lee WS (1997) Epstein-Barr virus associated hemophagocytic syndrome. A case report. J Korean Med Sci 12:447–451PubMed Kim IS, Park CK, Kim H, Lee YY, Ahn MJ, Lee WS (1997) Epstein-Barr virus associated hemophagocytic syndrome. A case report. J Korean Med Sci 12:447–451PubMed
10.
Zurück zum Zitat Larcher C, McQuain C, Berger C, Mitterer M, Quesenberry PJ, Huemer HP, Knecht H (1997) Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Ann Hematol 74:23–28CrossRefPubMed Larcher C, McQuain C, Berger C, Mitterer M, Quesenberry PJ, Huemer HP, Knecht H (1997) Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69-base pair deletion in the LMP1 oncogene. Ann Hematol 74:23–28CrossRefPubMed
11.
Zurück zum Zitat Mitterer M, Pescosta N, Fend F, Larcher C, Prang N, Schwarzmann F, Coser P, Huemer HP (1995) Chronic active Epstein-Barr virus disease in a case of persistent polyclonal lymphocytosis. Br J Haematol 90:526–531PubMed Mitterer M, Pescosta N, Fend F, Larcher C, Prang N, Schwarzmann F, Coser P, Huemer HP (1995) Chronic active Epstein-Barr virus disease in a case of persistent polyclonal lymphocytosis. Br J Haematol 90:526–531PubMed
12.
Zurück zum Zitat Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk F, Vogelman J (1989) Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689–695PubMed Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk F, Vogelman J (1989) Hodgkin’s disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 320:689–695PubMed
13.
Zurück zum Zitat Nazaruk RA, Rochford R, Hobbs MV, Cannon MJ (1998) Functional diversity of the CD8+ T-cell response to Epstein-Barr virus (EBV): implication for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 91:3875–3883PubMed Nazaruk RA, Rochford R, Hobbs MV, Cannon MJ (1998) Functional diversity of the CD8+ T-cell response to Epstein-Barr virus (EBV): implication for the pathogenesis of EBV-associated lymphoproliferative disorders. Blood 91:3875–3883PubMed
14.
Zurück zum Zitat Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T (2001) Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 183:1-7CrossRefPubMed Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T (2001) Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 183:1-7CrossRefPubMed
15.
Zurück zum Zitat Okano M, Gross TG (1996) Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 53:111–115CrossRefPubMed Okano M, Gross TG (1996) Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. Am J Hematol 53:111–115CrossRefPubMed
16.
Zurück zum Zitat Otteman LA, Greipp PR, Ruiz-Argüelles GJ, Banks PM, Li C-Y, Katzmann JA (1985) Infectious mononucleosis mimicking a B cell immunoblastic lymphoma associated with an abnormality in regulatory T cells Am J Med 78:885–890 Otteman LA, Greipp PR, Ruiz-Argüelles GJ, Banks PM, Li C-Y, Katzmann JA (1985) Infectious mononucleosis mimicking a B cell immunoblastic lymphoma associated with an abnormality in regulatory T cells Am J Med 78:885–890
17.
Zurück zum Zitat Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, Yokoi T, Kojima M, Kamiya Y, Taji H, Kagami Y, Ogura M, Saito H, Morishima Y, Nakamura S (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16–26CrossRefPubMed Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, Yokoi T, Kojima M, Kamiya Y, Taji H, Kagami Y, Ogura M, Saito H, Morishima Y, Nakamura S (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16–26CrossRefPubMed
18.
Zurück zum Zitat Quitanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443–451PubMed Quitanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443–451PubMed
19.
Zurück zum Zitat Ryon JJ, Hayward SD, MacMahon EM, Mann RB, Ling Y, Charache P, Phelan JA, Miller G, Ambinder RF (1993) In situ detection of lytic Epstein-Barr virus infection: expression of the Notl early gene and viral interleukin-10 late gene in clinical specimens. J Infect Dis 168:345–351PubMed Ryon JJ, Hayward SD, MacMahon EM, Mann RB, Ling Y, Charache P, Phelan JA, Miller G, Ambinder RF (1993) In situ detection of lytic Epstein-Barr virus infection: expression of the Notl early gene and viral interleukin-10 late gene in clinical specimens. J Infect Dis 168:345–351PubMed
20.
Zurück zum Zitat Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H, Kozuka T (2001) Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer 92:226–231CrossRefPubMed Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H, Kozuka T (2001) Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer 92:226–231CrossRefPubMed
21.
Zurück zum Zitat Simon M, Bartram CR, Friedrich W, Arnold R, Schmeiser T, Hampl W, Müller-Hermelink HK, Heymer B (1991) Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study. Virchows Arch B Cell Pathol 60:307–319 Simon M, Bartram CR, Friedrich W, Arnold R, Schmeiser T, Hampl W, Müller-Hermelink HK, Heymer B (1991) Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients. A clinical, immunobiological and pathological study. Virchows Arch B Cell Pathol 60:307–319
22.
Zurück zum Zitat Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185:1605–1617CrossRefPubMed Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185:1605–1617CrossRefPubMed
23.
Zurück zum Zitat Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB, Miura I (2001) A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74:209–213PubMed Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB, Miura I (2001) A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74:209–213PubMed
24.
Zurück zum Zitat Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N, Ohshima K (2000) Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin’s disease. Bone Marrow Transplant 26:1339–1341 Yufu Y, Kimura M, Kawano R, Noguchi Y, Takatsuki H, Uike N, Ohshima K (2000) Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin’s disease. Bone Marrow Transplant 26:1339–1341
25.
Zurück zum Zitat Weiss LM, Movahed L, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502–506PubMed Weiss LM, Movahed L, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. N Engl J Med 320:502–506PubMed
Metadaten
Titel
Lytic infection of Epstein-Barr virus (EBV) in hemophagocytic syndrome associated with EBV-induced lymphoproliferative disorder
verfasst von
T. Yamamoto
A. Shirakawa
M. Kawaguchi
A. Masuda
T. Nishikawa
M. Kobayashi
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 2/2004
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0776-0

Weitere Artikel der Ausgabe 2/2004

Annals of Hematology 2/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.